Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Evoxac (cevimeline hydrochloride)FDA approves Evoxac (cevimeline hydrochloride)15 October 2026The FDA approved Evoxac (cevimeline hydrochloride), a drug from Cosette Pharms NC. Form: Capsule, Oral. Application NDA221183.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

9 October 2026 - FDA approves Hovilpr (pritelivir)